TSVT Insider Trading

Insider Ownership Percentage: 7.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $25,462,068.53

2seventy bio Insider Trading History Chart

This chart shows the insider buying and selling history at 2seventy bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

2seventy bio Share Price & Price History

Current Price: $4.98
Price Change: Price Increase of +0.01 (0.20%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for TSVT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$4.98Closing price on 04/17/25:

SEC Filings (Institutional Ownership Changes) for 2seventy bio (NASDAQ:TSVT)

93.90% of 2seventy bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TSVT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$45ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M$0$20MTotal InflowsTotal Outflows
2seventy bio logo
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Read More on 2seventy bio

Today's Range

Now: $4.98
Low: $4.97
High: $4.99

50 Day Range

MA: $4.01
Low: $2.33
High: $4.98

52 Week Range

Now: $4.98
Low: $2.29
High: $5.30

Volume

444,665 shs

Average Volume

617,204 shs

Market Capitalization

$260.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of 2seventy bio?

2seventy bio's top insider investors include:
  1. Kynam Capital Management, Lp (Major Shareholder)
  2. Casdin Capital, Llc (Director)
  3. Nick Leschly (CEO)
  4. William D Baird III (CEO)
  5. Victoria Eatwell (CFO)
  6. Philip D Gregory (Insider)
  7. Jessica Snow (COO)
  8. William D Baird III (CFO)
  9. William D Baird III (COO)
  10. Jessica Snow (Insider)
  11. Marcela V Maus (Director)
  12. Global Healthcare Master Kynam (Major Shareholder)
Learn More about top insider investors at 2seventy bio.

Who are the major institutional investors of 2seventy bio?

2seventy bio's top institutional shareholders include:
  1. Exchange Traded Concepts LLC — 0.05%
Learn More about top institutional investors of 2seventy bio stock.

Which major investors are selling 2seventy bio stock?

During the previous quarter, TSVT stock was sold by these institutional investors:
  1. Exchange Traded Concepts LLC
In the previous year, company insiders that have sold 2seventy bio company stock include:
  1. Kynam Capital Management, Lp (Major Shareholder)
  2. Casdin Capital, Llc (Director)
  3. Nick Leschly (CEO)
  4. William D Baird III (CEO)
  5. Victoria Eatwell (CFO)
  6. Philip D Gregory (Insider)
Learn More investors selling 2seventy bio stock.